| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Feb 2025 | 4 Feb 2025 |
| Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 12, 2025 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31, 2024. Unaudited Results for quarter and nine months ended December 31, 2024. (As Per BSE Announcement Dated on: 12/02/2025) | ||
| Board Meeting | 25 Oct 2024 | 18 Oct 2024 |
| Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday October 25 2024 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30 2024. Unaudited Results for Quarter and Half Year ended September 30, 2024. (As per BSE Announcement Dated on 25/10/2024) | ||
| Board Meeting | 6 Aug 2024 | 30 Jul 2024 |
| Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday August 06 2024 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2024. Outcome of Board Meeting held on August 06, 2024, Considering and approving the Unaudited Standalone and Consolidated Financial Results of the Company for Quarter ended June 30, 2024 and other matters (As per BSE Announcement Dated on 06/08/2024) | ||
| Board Meeting | 18 May 2024 | 10 May 2024 |
| Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31 2024 and Recommendation of Final Dividend If Any for year ended March 31 2024. Outcome of Board Meeting held on May 18, 2024, Considering and approving the Audited Standalone and Consolidated Financial Results of the Company for Quarter and Year ended March 31, 2024 and other matters. (As Per BSE Announcement Dated on: 18/05/2024) | ||
This partnership will operate on a public-private partnership (PPP) basis, where Krsnaa will handle the supply, installation, commissioning, operation, and maintenance of the facilities.
Here are some of the stocks that may see significant price movement today: Mazagon Dock Shipbuilders, Krsnaa Diagnostics, Dr Reddy's, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
